Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival (Q33622587)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q116996864)
(P304) 161-172
(P407) (Q1860)
(P433) 2
(P478) 12
(P577) Monday, February 1, 2010
(P921) (Q61643320)
(Q18556145)
(P1104) 12
(P1433) (Q2962042)
(P1476) "Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival" (language: en)
(P2093) Adam Clauss
Vivian Ng
Joyce Liu
Huiying Piao
Moises Russo
Natalie Vena
Qing Sheng
Michelle S Hirsch
Tomas Bonome
Azra H Ligon
Michael J Birrer
Ronny Drapkin
(P2860) (Q28294122)
(Q36983005)
(Q33344596)
(Q36984251)
(Q27860585)
(Q29547234)
(Q40071945)
(Q30816447)
(Q28295249)
(Q36334980)
(Q40402325)
(Q24816796)
(Q24682006)
(Q34405149)
(Q40471068)
(Q35983071)
(Q34375262)
(Q34211073)
(Q35125949)
(Q24534896)
(Q42520239)
(Q24292100)
(Q40789940)
(Q38300661)
(Q33920067)
(Q33724007)
(Q36431252)
(Q46325670)
(Q42133049)
(Q42492470)
(Q28303134)
(Q24317644)
(Q24297909)
(Q46868536)
(Q44147137)
(Q42982851)
(Q48064816)
(Q80229967)
(Q81567647)
(Q81299152)
(Q74099915)
(Q73803404)
(Q73421716)
(Q73047864)
(Q73964412)
(Q81837012)
(P4510) (Q112270642)
other details
description scientific article

External Links